Jason Sicklick named co-leader of the Structural and Functional Genomics Research Program at UCSD Moores

John Ashton named associate director for shared resources at Wilmot Cancer Institute

John M. Ashton, associate professor in the department of biomedical genetics, has been promoted from assistant director to associate director of shared resources at the University of Rochester’s Wilmot Cancer Institute.

September 13, 2024

Vol.50 No.34

Drugs & Targets

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

Labcorp announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing clinical applications, including molecular residual disease in patients with early-stage solid tumor cancers.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Pan-cancer proteogenomics reveals potential drug targets

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets.

June 28, 2024

Vol.50 No.26

In Brief

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

Diane Simeone, director of Moores Cancer Center at UC San Diego Health, has expanded her leadership team.

June 14, 2024

Vol.50 No.24

Clinical Trials & Tribulations

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In May, the American Society of Clinical Oncology released guidelines on the use of germline genetic testing panels in concert with tumor testing for cancer patients. xxx:more

Alligator Bioscience initiates phase I study of intratumoral mitazalimab in locally advanced pancreatic cancer

Alligator Bioscience has announced the initiation of a phase I clinical study (NCT06205849) to evaluate the safety and efficacy of mitazalimab (CD40 mAb agonist) injected intratumorally at the time of surgical irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer.

May 17, 2024

Vol.50 No.20

Jason Sicklick named co-leader of the Structural and Functional Genomics Research Program at UCSD Moores

YOU MAY BE INTERESTED IN

John Ashton named associate director for shared resources at Wilmot Cancer Institute

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

Pan-cancer proteogenomics reveals potential drug targets

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Alligator Bioscience initiates phase I study of intratumoral mitazalimab in locally advanced pancreatic cancer

Renew today!

Subscriber content

Never miss an issue!

Login